Michael Aldridge
Chief Executive Officer at Advanced Chemotherapy Technologies, Inc.
Michael Aldridge active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of Canterbury Foundation In America, Inc. | Director/Board Member | 01/01/2015 | - |
Advanced Chemotherapy Technologies, Inc.
 Advanced Chemotherapy Technologies, Inc. Medical SpecialtiesHealth Technology Advanced Chemotherapy Technologies, Inc. develops a novel device for infusing chemotherapies directly into poorly-vascularized pancreatic tumors. The company was founded by Joseph DeSimone and Jen Jen Yeh and is headquartered in Raleigh, NC. | Chief Executive Officer | 01/11/2022 | - |
Career history of Michael Aldridge
Former positions of Michael Aldridge
| Companies | Position | Start | End |
|---|---|---|---|
| HEXIMA LIMITED | Director/Board Member | 21/05/2019 | 05/09/2023 |
| Chief Executive Officer | 01/09/2020 | 02/08/2022 | |
| CODEXIS, INC. | Corporate Officer/Principal | 01/10/2016 | 17/08/2018 |
Sirona Therapeutics Ltd.
 Sirona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sirona Therapeutics Ltd. is an Irish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dublin, Ireland. The company was founded by Michael Douglas Arthur Aldridge. | Director/Board Member | 01/07/2015 | 01/07/2017 |
| Chief Executive Officer | 01/10/2015 | 01/07/2017 | |
| Founder | 01/10/2015 | 01/07/2017 | |
| President | 01/10/2015 | 01/07/2017 | |
| QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2012 | 01/09/2014 |
| ALLON THERAPEUTICS INC. | Director/Board Member | 08/07/2011 | 30/01/2013 |
| Independent Dir/Board Member | 30/06/2011 | 30/01/2013 | |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Director/Board Member | 01/05/2010 | 01/09/2012 |
| Chief Executive Officer | 01/05/2010 | 01/09/2012 | |
Peplin, Inc.
 Peplin, Inc. Pharmaceuticals: MajorHealth Technology Peplin, Inc. develops drugs and pharmaceutical products. The company was founded by James Harrison Aylward in 1998 and is headquartered in Emeryville, CA. | Director/Board Member | 01/09/2003 | 01/01/2009 |
| Chief Executive Officer | 01/09/2003 | 01/01/2009 | |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░ ░░░░░░ ░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Michael Aldridge
| University of Canterbury | Undergraduate Degree |
| Macquarie University | Graduate Degree |
Statistics
International
| United States | 8 |
| Australia | 5 |
| United Kingdom | 2 |
Operational
| Director/Board Member | 8 |
| Chief Executive Officer | 5 |
| Corporate Officer/Principal | 4 |
Sectoral
| Health Technology | 8 |
| Finance | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| PINNACLE INVESTMENT MANAGEMENT GROUP LIMITED | Finance |
| ALLON THERAPEUTICS INC. | Health Technology |
| CODEXIS, INC. | Process Industries |
| HEXIMA LIMITED | Health Technology |
| Private companies | 9 |
|---|---|
Peplin, Inc.
Peplin, Inc. Pharmaceuticals: MajorHealth Technology Peplin, Inc. develops drugs and pharmaceutical products. The company was founded by James Harrison Aylward in 1998 and is headquartered in Emeryville, CA. | Health Technology |
| Volpe Brown Whelan & Co. LLC | Finance |
S.G. Warburg Group Plc
 S.G. Warburg Group Plc Investment Banks/BrokersFinance S.G. Warburg Group Plc provides investment banking services. The company is focusing on mergers and acquisitions. It was founded in 1934 and is headquartered in London, the United Kingdom. | Finance |
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
Bear, Stearns & Co., Inc.
 Bear, Stearns & Co., Inc. Investment Banks/BrokersFinance Bear, Stearns & Co., Inc. is a global investment banking, securities trading and brokerage firm located in New York City with additional offices in Dallas, Boston and San Francisco. The firm is a subsidiary Bear Sterns Cos., Inc. (NYSE: BSC). Their equity research team consists of senior analysts located throughout the world. In addition to domestic coverage, they have research teams focusing on Latin America, Asia and Europe. The analysts use a bottom-up approach to stock selection. The Bear Stearns fixed-income research department provides coverage of every sector of the fixed-income universe. The financial analytics and structured transactions group (F.A.S.T) provides investment research, fixed-income portfolio management and analytical systems, trading technology and general financial expertise. The group also provides a broad range of services to financial institutions including asset-liability management, balance sheet restructuring, receivables-based financing analysis, security and portfolio analysis, peer analysis, and historical and real-time market-based information. | Finance |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Sirona Therapeutics Ltd.
Sirona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Sirona Therapeutics Ltd. is an Irish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dublin, Ireland. The company was founded by Michael Douglas Arthur Aldridge. | Health Technology |
| University of Canterbury Foundation In America, Inc. | |
Advanced Chemotherapy Technologies, Inc.
Advanced Chemotherapy Technologies, Inc. Medical SpecialtiesHealth Technology Advanced Chemotherapy Technologies, Inc. develops a novel device for infusing chemotherapies directly into poorly-vascularized pancreatic tumors. The company was founded by Joseph DeSimone and Jen Jen Yeh and is headquartered in Raleigh, NC. | Health Technology |
- Stock Market
- Insiders
- Michael Aldridge
- Experience